Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001885457 | SCV002113909 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2022-07-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489949 | SCV002790122 | uncertain significance | Ehlers-Danlos syndrome, classic type, 1; Fibromuscular dysplasia, multifocal | 2021-11-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003416499 | SCV004117727 | uncertain significance | COL5A1-related disorder | 2022-09-21 | criteria provided, single submitter | clinical testing | The COL5A1 c.700T>C variant is predicted to result in the amino acid substitution p.Tyr234His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-137619157-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
PG23_Medical Genetics Lab, |
RCV002509707 | SCV002819258 | uncertain significance | Confusion | no assertion criteria provided | clinical testing |